Spread over 1,25,000 sq. ft. the R&D Center at Mahape on the outskirts of Mumbai, India has end-to-end capabilities for discovery and development of New Chemical Entities (NCEs) from target selection to clinical development. The research facility is equipped with state-of-the-art infrastructure required to carry out research activities like medicinal chemistry, process & analytical chemistry, in vitro & in vivo studies and project management.
Neuchatel, Switzerland (NBE research)
Glenmark has established a dedicated research and development centre for biologics in Switzerland.
Glenmark has end-to-end capabilities to discover and develop Novel Biological Entities (NBEs) and for preclinical and clinical studies. It is also fully equipped to manufacture clinical trail size batch materials.
Glenmark is the only Indian company to have a R&D centre of this size outside India.